FindTrial
Sign In

A Randomized Control study To Assess The Efficacy Of topical keratolytics versus keratolytics delivered through iontophoresis in the treatment of wart over soles at a tertiary care centre

A Randomized Control Trial To Assess The Efficacy Of 16.7%Salicylic Acid With 16.7%Lactic Acid Iontophoresis Versus Topical 16.7%Salicylic Acid With 16.7%Lactic Acid In The Treatment Of Plantar Verrucae At A Tertiary Care Centre.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/049095
Enrollment
30
Registered
2023-01-18
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: 16.7% salicylic acid with 16.7% lactic acid iontophoresis versus topical 16.7% salicylic acid with 16.7% lactic acid: Group A were treated with topical 16.7% salicylic acid with 16.7% l

Sponsors

Menagadevi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ï?¬ plantar verrucae for 1months or greater ï?¬ They should not have received any treatment for the wart(s) within 4 weeks of participation in the study Patients more than 12 years and less than 60 years of age of both genders. Willingness to take part in the study.

Exclusion criteria

Exclusion criteria: Uncontrolled diabetes HIV infection. History of taking immunocompromise medications. circulatory or sensory disorders,

Design outcomes

Primary

MeasureTime frame
decrease in number and size of wartTimepoint: At baseline,4weeks,8 weeks,12 weeks—

Secondary

MeasureTime frame
safety profileTimepoint: 12 weeks—

Countries

India

Contacts

Public ContactBMenagadevi

Chengalpattu medical college

dermcliniccmch@gmail.com8489686883

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026